PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Est. Return
33.7%
1 Year Est. Return
+33.7%
AUM
$864M
AUM Growth
+$21.2M
(+2.5%)
Holding
103
Top Buys
| 1 | +$17.3M | |
| 2 | +$16.2M | |
| 3 | +$9.25M | |
| 4 |
DexCom
DXCM
|
+$8.34M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$7.63M |
Top Sells
| 1 | +$27.6M | |
| 2 | +$26.3M | |
| 3 | +$10.8M | |
| 4 |
Gilead Sciences
GILD
|
+$9.68M |
| 5 |
Tenet Healthcare
THC
|
+$7.84M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLN
101
Silence Therapeutics
SLN
$337M
| – | – |
-401,746
|
|
||
102
UnitedHealth
UNH
$331B
| – | – |
-50,213
|
|
||
103
VYNE Therapeutics
VYNE
$9.2M
| – | – |
-217,978
|
|